CureVac claims advantage in BioNTech patent dispute
A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba
Virgin Pulse eyes $3bn merger with HealthComp
Digital health and wellness company Virgin Pulse has said it plans to merge with HealthComp, a health benefits administrator, in a $3 billion transaction that would create
US channels $104m into antimicrobial resistance project
The US government has set aside a $104 million pot of funding for research into bacterial behaviour and antibiotic resistance, in the hope of speeding up diagnosis and ena
FDA advisors unconvinced by BrainStorm’s ALS cell therapy
An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to su
BridgeBio’s $250m raise heads latest biotech financings
BridgeBio Pharma has raised $250 million from the sale of nine million shares that is earmarked for the commercial launch of its acoramidis drug for transthyretin amyloido
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
Oncology
Patients
R&D
Partner Content
CRISPR-Based Therapy Analytical Development Summit
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.
4th Annual CRISPR 2.0 2023
CRISPR represents the next frontier in the cell and gene therapy landscape.
5th Annual Gene Therapy Analytical Development Summit 2023
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development.
2nd Molecular Glue Drug Development Summit 2024
Molecular glue development continues to gain exponential momentum, with advances in screening tools, identification assays and structure-based design.
mRNA Assay Development Summit 2023
The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development.